Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$355M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$304M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$267M |
| 4 |
Gilead Sciences
GILD
|
+$239M |
| 5 |
Visa
V
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$388M |
| 2 |
Wells Fargo
WFC
|
+$370M |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$295M |
| 4 |
Alibaba
BABA
|
+$234M |
| 5 |
IBM
IBM
|
+$210M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.55% |
| 2 | Healthcare | 5.29% |
| 3 | Financials | 4.23% |
| 4 | Communication Services | 3.53% |
| 5 | Energy | 2.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Visteon
VC
$2.8B
| $74K | ﹤0.01% |
935
-238
| -20% | -$18.7K |
|
|
VIVO
4452
CALL
DELISTED
Meridian Bioscience Inc
VIVO
| $74K | ﹤0.01% |
3,700
+1,100
| +42% | +$21.7K |
|
|
YELL
4453
PUT
DELISTED
Yellow Corporation Common Stock
YELL
| $74K | ﹤0.01% |
8,200
-208,400
| -96% | -$1.98M |
|
4454
CALL
Accuray
ARAY
$34.9M
| $73K | ﹤0.01% |
14,500
+12,600
| +663% | +$69.8K |
|
4455
PUT
ManpowerGroup
MAN
$2.63B
| $73K | ﹤0.01% |
900
-1,500
| -63% | -$115K |
|
4456
CALL
NovaGold Resources
NG
$3.35B
| $73K | ﹤0.01% |
14,600
-35,100
| -71% | -$162K |
|
|
HMHC
4457
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $73K | ﹤0.01% |
3,864
+3,819
| +8,487% | +$70.3K |
|
|
VVC
4458
DELISTED
Vectren Corporation
VVC
| $73K | ﹤0.01% |
1,477
-6,478
| -81% | -$292K |
|
|
HSNI
4459
CALL
DELISTED
HSN, Inc.
HSNI
| $73K | ﹤0.01% |
+1,400
| New | +$69.5K |
|
4460
PUT
First Majestic Silver
AG
$9.29B
| $72K | ﹤0.01% |
12,000
-26,900
| -69% | -$117K |
|
4461
PUT
Exelixis
EXEL
$13.1B
| $72K | ﹤0.01% |
18,100
+6,900
| +62% | +$29.2K |
|
4462
Globant
GLOB
$1.66B
| $72K | ﹤0.01% |
2,405
-2,051
| -46% | -$61.8K |
|
|
HIMX
4463
PUT
Himax Technologies
HIMX
$2.57B
| $72K | ﹤0.01% |
6,500
-22,300
| -77% | -$196K |
|
|
KNDI
4464
PUT
Kandi Technologies Group
KNDI
$63.1M
| $72K | ﹤0.01% |
10,300
-600
| -6% | -$4.66K |
|
4465
CALL
Lazard
LAZ
$4.16B
| $72K | ﹤0.01% |
1,900
-25,900
| -93% | -$930K |
|
|
SGI
4466
CALL
Somnigroup International
SGI
$13.6B
| $72K | ﹤0.01% |
4,800
-34,000
| -88% | -$504K |
|
|
QVCGA
4467
CALL
DELISTED
QVC Group Inc Series A
QVCGA
| $72K | ﹤0.01% |
59
-273
| -82% | -$333K |
|
|
OTIC
4468
DELISTED
Otonomy, Inc.
OTIC
| $72K | ﹤0.01% |
5,190
+148
| +3% | +$2.33K |
|
|
CETV
4469
DELISTED
Central European Media Enterprises Ltd
CETV
| $72K | ﹤0.01% |
36,220
-4,280
| -11% | -$10.4K |
|
|
EBIX
4470
DELISTED
Ebix Inc
EBIX
| $72K | ﹤0.01% |
1,796
-43,631
| -96% | -$1.52M |
|
|
MWW
4471
CALL
DELISTED
Monster Worldwide Inc
MWW
| $72K | ﹤0.01% |
24,100
+23,600
| +4,720% | +$91.8K |
|
4472
CALL
RenaissanceRe
RNR
$13.2B
| $71K | ﹤0.01% |
600
-1,200
| -67% | -$136K |
|
|
XYZ
4473
PUT
Block Inc
XYZ
$47.5B
| $71K | ﹤0.01% |
4,700
+3,200
| +213% | +$34.7K |
|
|
DNR
4474
DELISTED
Denbury Resources, Inc.
DNR
| $71K | ﹤0.01% |
35,463
+24,863
| +235% | +$41.4K |
|
|
NTRI
4475
DELISTED
NutriSystem, Inc.
NTRI
| $71K | ﹤0.01% |
3,593
-1,590
| -31% | -$31.4K |
|
Similar funds
Barclays's Q1 2016 Portfolio in Review
As of Q1 2016, Barclays held 6,944 positions worth $65.6B, down 20% from $82.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays withdrew a net $15.2B in Q1 2016, closing 588 positions and reducing 2,924 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $295M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.5% of assets, up from 4.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in State Street SPDR S&P Pharmaceuticals ETF worth $26M.
- Barclays's largest Q1 2016 buy was State Street SPDR S&P Pharmaceuticals ETF: 650,000 shares worth $26M.
- Barclays added most to KLA in Q1 2016, an estimated $355M increase.
- Barclays's biggest Q1 2016 reduction was Apple, cutting an estimated $388M.
- Barclays fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $295M.
- Barclays's ten largest holdings make up 29% of its $65.6B portfolio in Q1 2016.
- Barclays opened 766 new positions and closed 588 in Q1 2016.
- Barclays's portfolio value fell 20% quarter-over-quarter to $65.6B.
Based on Barclays's 13F filing for Q1 2016, filed 16 May 2016.